1. Home
  2. NEXN vs ANNX Comparison

NEXN vs ANNX Comparison

Compare NEXN & ANNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nexxen International Ltd. American Depository Shares

NEXN

Nexxen International Ltd. American Depository Shares

HOLD

Current Price

$6.46

Market Cap

367.2M

Sector

Technology

ML Signal

HOLD

Logo Annexon Inc.

ANNX

Annexon Inc.

HOLD

Current Price

$4.62

Market Cap

334.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NEXN
ANNX
Founded
2007
2011
Country
Israel
United States
Employees
N/A
N/A
Industry
Computer Software: Programming Data Processing
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
367.2M
334.1M
IPO Year
2021
2020

Fundamental Metrics

Financial Performance
Metric
NEXN
ANNX
Price
$6.46
$4.62
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
9
5
Target Price
$12.13
$16.60
AVG Volume (30 Days)
434.2K
3.3M
Earning Date
11-13-2025
11-10-2025
Dividend Yield
N/A
N/A
EPS Growth
237.45
N/A
EPS
0.62
N/A
Revenue
$376,353,000.00
N/A
Revenue This Year
$5.43
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$10.41
N/A
Revenue Growth
7.80
N/A
52 Week Low
$6.08
$1.29
52 Week High
$12.60
$5.66

Technical Indicators

Market Signals
Indicator
NEXN
ANNX
Relative Strength Index (RSI) 34.86 67.57
Support Level $6.35 $4.01
Resistance Level $6.71 $4.64
Average True Range (ATR) 0.26 0.37
MACD 0.06 0.05
Stochastic Oscillator 29.70 81.06

Price Performance

Historical Comparison
NEXN
ANNX

About NEXN Nexxen International Ltd. American Depository Shares

Nexxen International Ltd is a globalized and flexible advertising technology platform with deep expertise in data and advanced TV that helps empower advertisers, agencies, digital publishers and broadcasters to achieve desired outcomes, including increased efficiency and returns, across the media supply chain. It is a demand-side platform (DSP), supply-side platform (SSP), ad server, and data management platform (DMP) and also delivers a flexible and unified technology stack with and exclusive data at its core. Company operates in America, APAC, EMEA, regions, with majority revenue from America.

About ANNX Annexon Inc.

Annexon Inc is a clinical-stage biopharmaceutical company developing a pipeline of novel therapies for patients with classical complement-mediated disorders of the body, brain, and eye. Its pipeline is based on its platform technology addressing well-researched classical complement-mediated autoimmune and neurodegenerative disease processes, both of which are triggered by aberrant activation of C1q. Its pipeline of product candidates is designed to block the activity of C1q and the entire classical complement pathway in a broad set of complement-mediated diseases. Its product candidates are ANX005, for autoimmune & neurodegenerative disorders; ANX007, for neurodegenerative ophthalmic disorders; ANX1502 for Oral small molecule; and ANX009, for systemic autoimmune diseases.

Share on Social Networks: